Minalax
laxative Tablets
Composition :
Each enteric coated tablet contains:
Bisacodyl 5 mg.
Dioctyl sodium sulphosuccinate (Sodium Docusate) 100 mg.
Properties :
Minalax® is an enteric coated laxative tablet that combines the two criteria of potent efficacy and gentle action through the synergistic effects of restoring normal Intestinal motility and softening of hard stool which are achieved through Its dual components of Bisacodyl and Sodium Docusate.
Bisacodyl belongs to the group of stimulant laxative that acts by directly stimulating nerve endings in the colonic mucosa thereby restoring normal intestinal motility. , Sodium sulphosuccinate (Sodium Docusate) belongs to the group of emollient laxative
(fecal softener) that acts by decreasing surface tension and increasing penetration of Intestinal fluid into h fec.a ss leading,
softening.
Indications :
– For the treatment of all forms of constipation, either acute, chronic or recurrent.
– For bowel evacuation either as preparation for radiography, sigmoidoscopy and proctoscopy or as preoperative preparation _In gastro.intestinal and colorectal surgeries.
– For the prevention of constipation wnenever straining is better to be avoided as in pregnant or postpartum women, elderly,
patients with painful anal conditions (fissures and/or hemorrhoids) and those with cardiovascular diseases.
Dosage :
Unless otherwise prescribed by the physician, the recommended dose is:
For Adults : 1-2 tablets at bed time
Children above 6 years : 1 tablet at bed time
How Supplied :
Strips of 10 enteric coated tablets in packs of 1 strip.
Keep all medicaments out of reach of children
Product of :
AMOUN PHARMACEUTICAL CO. SAE.
EI-Obour City, Cairo, Egypt
